The company's news release is printed below:
The Company intends to appeal the NYSE’s decision.
The Company anticipates that effective November 3, 2020, CBL’s common stock, Depositary Shares representing interest in its Series D Preferred Stock and Depositary Shares representing interest in its Series E Preferred Stock, will commence trading on the OTC Markets, operated by the OTC Markets Group, Inc., under the symbols “CBLAQ,” “CBLDQ” and “CBLEQ,” respectively.
The Company anticipates that effective November 3, 2020, CBL’s common stock, Depositary Shares representing interest in its Series D Preferred Stock and Depositary Shares representing interest in its Series E Preferred Stock, will commence trading on the OTC Markets, operated by the OTC Markets Group, Inc., under the symbols “CBLAQ,” “CBLDQ” and “CBLEQ,” respectively.
The transition to the over-the-counter market will not affect the Company’s business operations. Investors can find quotes for the Company’s common stock on www.otcmarkets.com.
No comments:
Post a Comment